DVN vs MRSN · P/E 7.4, rev $7.42B vs rev $40.5M
Devon Energy Corporation (DVN) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Devon Energy Corporation (DVN) is a oil & gas e&p company listed on US.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported DVN revenue for 2026-06-30 was $7.42B. Net income was $1.91B. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
DVN currently screens at market cap $22.42B and trailing P/E 7.4. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the DVN and MRSN stock pages for the full models.
Not investment advice.